White, John KerrMohanty, SoumitraMuhammad, Tajde Arriba Sanchez de la Campa, MagdalenaHoussen, Wael EFerraz, NataliaGöransson, UlfBrauner, Annelie2023-06-262023-06-262023-05-12White, J K, Mohanty, S, Muhammad, T, de Arriba Sanchez de la Campa, M, Houssen, W E, Ferraz, N, Göransson, U & Brauner, A 2023, 'A synthetic cyclized antimicrobial peptide with potent effects against drug resistant skin pathogens', ACS Infectious Diseases, vol. 9, no. 5, pp. 1056-1063. https://doi.org/10.1021/acsinfecdis.2c005982373-8227https://hdl.handle.net/2164/21003Acknowledgments We would like to thank Anna Blasi-Romero for helping with the set-up of the initial scanning electron microscopy experiments. This project was partially supported by the Stiftelsen Olle Engkvist Byggmästare (AB 186 678), Region Stockholm (AB, ALF project 995080), a fellowship grant from the EPSRC (no. EP/S027246/1, W.E.H.), the Bo Rydin Foundation (no. F30/20; NF), the Swedish Research Council (# no. 2011-3403; UG); and Postdoctoral scholarship by Elisabeth and Alfred Ahlqvists Stiftelse, Apotekarsocieteten (TM). The graphical abstract was created with a BioRender standard academic license.85677822engKeratinocytes;MRSAsynthetic antimicrobial peptideLL-37bactericidal peptideWound closureR MedicineEngineering and Physical Sciences Research Council (EPSRC)EP/S027246/1Supplementary InformationRJournal article10.1021/acsinfecdis.2c0059895